GEOMX

Serial Number 87914539
602

Registration Progress

Application Filed
May 9, 2018
Under Examination
Feb 5, 2019
Approved for Publication
Dec 11, 2018
Published for Opposition
Dec 11, 2018
Registered

Trademark Image

GEOMX

Basic Information

Serial Number
87914539
Filing Date
May 9, 2018
Published for Opposition
December 11, 2018
Abandonment Date
June 6, 2022
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 16, 2022
Classes
005

Rights Holder

NanoString Technologies, Inc.

03
Address
530 Fairview Avenue North
Seattle, WA 98109

Ownership History

NanoString Technologies, Inc.

Original Applicant
03
Seattle, WA

NanoString Technologies, Inc.

Owner at Publication
03
Seattle, WA

Legal Representation

Attorney
Alyssa Worsham

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description Documents
Jun 16, 2022 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jun 16, 2022 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 3, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Dec 3, 2021 GNRT O NON-FINAL ACTION E-MAILED Loading...
Dec 3, 2021 CNRT W SU - NON-FINAL ACTION - WRITTEN Loading...
Aug 30, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 19, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 17, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 16, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Aug 16, 2021 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 5, 2021 IUAF S USE AMENDMENT FILED Loading...
Aug 5, 2021 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 5, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 5, 2021 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 22, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 20, 2021 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 20, 2021 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 20, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jul 22, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 20, 2020 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jul 20, 2020 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 20, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 1, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 30, 2020 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 30, 2020 EXT2 S SOU EXTENSION 2 FILED Loading...
Jan 30, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 29, 2019 NOAC E CORRECTED NOA E-MAILED Loading...
Oct 28, 2019 DPCC D DIVISIONAL PROCESSING COMPLETE Loading...
Oct 25, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Oct 23, 2019 DRRR I DIVISIONAL REQUEST RECEIVED Loading...
Oct 23, 2019 ERTD I TEAS REQUEST TO DIVIDE RECEIVED Loading...
Oct 3, 2019 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 2, 2019 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 2, 2019 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Aug 15, 2019 NREV E NOTICE OF REVIVAL - E-MAILED Loading...
Aug 15, 2019 TPEX I SOU EXTENSION RECEIVED WITH TEAS PETITION Loading...
Aug 15, 2019 PETG O PETITION TO REVIVE-GRANTED Loading...
Aug 15, 2019 PROA I TEAS PETITION TO REVIVE RECEIVED Loading...
Aug 5, 2019 EXT1 S SOU EXTENSION 1 FILED Loading...
Feb 5, 2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Dec 11, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 11, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 21, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 2, 2018 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 2, 2018 ALIE A ASSIGNED TO LIE Loading...
Oct 18, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 15, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 14, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 14, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 31, 2018 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED Loading...

Detailed Classifications

Class 005
diagnostic reagents and instruments for medical or veterinary use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; diagnostic reagent kits comprising primarily of diagnostic reagents for medical or veterinary use in the fields of cancer, neurology and infectious disease; chemical reagents for medical use; reagents for medical or veterinary use containing antibodies and nucleic acids; diagnostic test kits for medical use comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical or veterinary diagnostic kits comprising medical or veterinary diagnostic reagents for use in detecting the presence of analytes in samples and identifying sample type, and equipment, namely, medical diagnostic immuno-assays for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; diagnostic preparations in the nature of antibodies, for medical and veterinary purposes; reagents and diagnostic reagents for medical or veterinary purposes; diagnostic preparations in the nature of in situ hybridization probes, for medical and veterinary purposes; medical or veterinary diagnostic reagents for pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; multiparameter quantitative detection and analysis products and technology for diagnostics for a variety of uses in health care, namely, pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents and assays for testing of body fluids or tissue; kits consisting primarily of medical or veterinary diagnostic reagents and assays for testing of body fluids or tissue; reagents in the form of cell markers and molecule markers including antibodies and nucleic acids for medical or veterinary purposes; medical diagnostic reagents for use in the fields of pathology, immunohistochemistry, in situ-hybridization, proteomics, RNA transcription, RNA translation, gene expression profiling and nucleic acid sequencing; medical diagnostic reagents for use relating to molecular identification and digital quantification; medical diagnostic reagents containing antibodies and nucleic acids; medical diagnostic reagents for use in the fields of cancer, neurology and infectious disease; medical diagnostic reagents for immuno-histochemistry detection and in situ-hybridization detection; medical diagnostic reagents for use relating to molecular identification and digital quantification
First Use Anywhere: Sep 5, 2018
First Use in Commerce: Sep 5, 2018

Classification

International Classes
005